Home
- Naturade Significantly Strengthens Balance Sheet; Receives $2.5 Million in Capital from Westgate Equity Partners, L.P.
- Natrol Appoints Vincent Andrich VP Sales for Prolab Division
- Vermont Pure Holdings, Ltd. Announces Record Fiscal Year 2001 Results
- Body Shop Reports 24.8 Mil Euro Sales Revenues
- Spectrum Organic Products Responds to FDA Letter Regarding Use of Non-GMO Seal on Canola Oil Label
- Supplement Group Targets Consumer Education
- Advanced Nutraceuticals, Inc. Announces 2001 Year End Results And Additional Financing
- ADM Awarded Nutraceuticals Patent Patent Creates Proprietary Position for ADM in Fast-Growing Nutraceutical Market
- Tantivy Sciences Obtains Exclusive License to Unique Nutraceutical Products
- Top GNC Executives Tour Pittsburgh Market to Present New Business Plan and Expansion Possibilities; Meeting will focus on new business strategies and growth
- Nutrition 21 Receives Patent For the Nutritional Treatment of Type 2 Diabetes; Patent Presents New Pharmaceutical Licensing Opportunities
- ConsumerLab.com Finds Most B-vitamin Supplements Contain What They Claim, But Often Exceed Safe Levels - Consumers Cautioned to Be Aware of Side Effects with High Dose Products
- Nutraceutix, Inc., Nutravite Announcement Commercial Availability of CDT™ Glucosamine for Canadian Marketplace
- Harvey Kamil Appointed President of NBTY, Inc. - Scott Rudolph to Continue as Chairman and CEO
- drugstore.com Expects to Reach Profitability Target in 2003
- Human Genome Project Leads to Innovative Healthcare
- NPIcenter’s Career Center targets nutraceutical Industry
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Adding Vitamin C To Certain Drugs May Help Treat Alzheimer's, Other Brain Disorders
- Editorial: An Exercise in Synergy
- NBTY, Inc. Appoints Harvey Kamil President, Scott Rudolph To Continue As Chairman And CEO
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- Ross Products to Launch Infant Formula Supplemented With Two New Fatty Acids
- LignisulMSM vs Naproxen for Osteoarthritis Clinical Trial Gets Underway
- Natural Health Trends Corp. Launches Lexxus Taiwan
- FDA Presents Compliance Guide for Structure/Function Claims
- New TrimFit® Bars Redefine Energy Bar Category
- New TrimFit® Bars Redefine Energy Bar Category
- Probiata® Offers Safe, Natural and Effective Alternative
- Alive & Well with Michelle Harris
- Be Well and Get Rewarded! Find Personalized Wellness Solutions and Earn Free Vitamins at NatureMade.com
- Consumers Search for Healthy Cleaning Products That Work
- Nordic Naturals: Omega 3 Fatty Acids
- Cyanotech Names Bob Capelli as Director of Sales
- New Studies Show that FenuLife Lowers Blood Sugar Levels
- New Studies Show that FenuLife Lowers Blood Sugar Levels
- New Studies Show that FenuLife Lowers Blood Sugar Levels
- Emerging Research Reveals Important Role of Chromium Picolinate in Insulin Resistance and Chronic Disease
- Emerging Research Reveals Important Role of Chromium Picolinate in Insulin Resistance and Chronic Disease
- New Clinical Trial Adds to Body of Evidence Showing Chromium Picolinate Lowers Blood Sugar in Insulin-Treated People with Poorly-Controlled Type 2 Diabetes
- New Clinical Trial Adds to Body of Evidence Showing Chromium Picolinate Lowers Blood Sugar in Insulin-Treated People with Poorly-Controlled Type 2 Diabetes
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- Harvard Study Links Low Chromium Levels to Increased Risk of Heart Disease In Men with Diabetes
Retrospective analysis from the Harvard Health Professionals Follow-up Study showed that men with diabetes and cardiovascular disease had 46% less chromium in toenails than healthy subjects.
- New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes
Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%.
- New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes
Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%.
- New Clinical Study Shows Walnuts Protective for People with Type 2 Diabetes
Australian study published in the December 2004 issue of Diabetes Care, shows that, for patients with type 2 diabetes, a whole foods diet including walnuts can reduce LDL "bad" cholesterol by 10%.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- Nutrition 21 and XL Health Report Positive Results for Diachrome Clinical Trial in People with Type 2 Diabetes
Companies announce results of 453 patient multi-center trial, the largest U.S. study to demonstrate the health benefits of a chromium-based intervention for diabetes.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- New Study Finds Cocoa Flavanols May Lower Blood Pressure, Improve Insulin Response
Study from Italy's University of L'Aquila, published in this month's American Journal of Clinical Nutrition, is consitent with previous research that suggests that naturally occurring flavanol compounds found in certain cocoa and chocolates may provide heart health benefits.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- Study on Pharmanex Tegreen 97(R) Finds Benefits in Blood Sugar Control and Weight Loss
Study recently presented at the American Heart Association's Sixth Annual Conference indicates that Tegreen 97(R) provides blood sugar control, body fat burning properties and weight-loss benefits in an experimental setting of Metabolic Syndrome X subjects.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Trial Shows Diachrome Improves Diabetes Care for Patients with Poorly-Controlled Blood Sugar Levels on Prescription Medications
Results from a new clinical trial that show daily supplementation with Diachrome(R)can improve uncontrolled blood sugar levels and cardiovascular risk factors in people with type 2 diabetes on prescription medications in a managed care setting; study evaluated 369 subjects and was presented at the American Diabetes Association (ADA) 65th Annual Scientific Sessions in San Diego, CA.
- New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes
Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes.
- New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes
Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes.
- New Clinical Study Further Evidence: Walnuts Protective for People with Type 2 Diabetes
Study published in the July 2005 issue of the Journal of the American Dietetic Association indicates that the intake of 30 grams of walnuts a day in conjunction with 350g of oily fish a week enabled achievement of recommendations on the type of fat in an energy-controlled diet for the management of diabetes.
- New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes
Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL
- New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes
Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL
- New Study Results Reaffirms Diachrome® Significantly Improves Cardiovascular Disease Risk Factors In People With Type 2 Diabetes
Results of Clinical Trial Examining Effects of Diachrome on Atherogenic Index of Plasma Presented at 2nd International Symposium on Triglycerides and HDL
- Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia
Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols.
- Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia
Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols.
- Research Finds Flavanols in Cocoa May Help Treat Diabetes, Strokes and Dementia
Mars scientists have discovered that entire "libraries" of cocoa flavanols can be synthesized, and that new flavanols can be developed from natural flavanols.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- Study Confirms Cinnulin PF Effectively Increases Insulin Sensitivity in Pre-Diabetes Sufferers
placebo-controlled, double-blind study conducted by the Ohio Research Group examined the effect of supplementation with Cinnulin PF on blood glucose regulation, lipid profiles and body composition in pre-diabetic men and women, indicating that subjects in the Cinnulin PF group noted statistically significant decreases in fasting blood glucose levels, marked improvements in insulin sensitivity.
- New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes
Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women.
- New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes
Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women.
- New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes
Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women.
- New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes
Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women.
- New Study Suggests that Supplementation with L-Carnipure® Tartrate During Pregnancy Can Reduce Increased Levels of Plasma Free Fatty Acids, a Major Factor in Gestational Diabetes
Company-supported study, conducted at the University of Vienna (Austria), published in Chemical Monthly, observes that supplementation with L-Carnipure® tartrate during pregnancy can significantly reduce the increased level of plasma free fatty acids, considered the main cause of insulin resistance, a major factor in gestational diabetes in pregnant women.
- Study: Chromium Picolinate May Provide Cardiovascular Benefits in Pre-Diabetes
Preclinical study on rats, conducted at the University of Alberta, and presented at the 3rd World Congress on Insulin Resistance Syndrome, shows daily use of chromium picolinate provides significant cardiovascular benefits in pre-diabetic rats that have insulin resistance
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award
The 2009 Frost & Sullivan European Functional Food & Beverage Microencapsulation Technology Innovation Award has been presented to GAT Food Essentials GmbH in recognition of its proprietary wowCAPS(R) technology.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates
Bio-Extraction Inc., has announced that it has completed the self-affirmation process to qualify its specialty canola protein products, Isolexx(TM) and Vitalexx(TM), as self-affirmed GRAS for their intended use in various foods and beverages, thus providing a basis for the sale of these products in the United States when commercial production commences in Q1 2010.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Synergy Flavors Invests in Sensory Flavor Profiling Research
Synergy Flavors has commissioned a new research program at North Carolina State University to study the sensory profiles of a range of protein ingredients.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
Synergy Flavors Inc., has announced their chocolate flavors offer a versatile solution for cocoa reduction and can be used as cocoa extenders.
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- NPI Daily - Top of The News for Nov. 20, 2009 - FDA Issues 22 Warning Letters to Website Operators
Frost & Sullivan Honours GAT Food Essentials GmbH With European Functional Food & Beverage Microencapsulation Technology Innovation Award; Synergy Flavors Invests in Sensory Flavor Profiling Research; FDA Issues 22 Warning Letters to Website Operators; Nordic Naturals Ultimate Omega™ First Fish Oil to Participate in NFL/NFLPA Sports Nutrition Label Certification Program; BioExx Achieves Self-Affirmed GRAS Status for Protein Isolates; New Organic Berry Whole Food Energy Bar from Amazing Grass Delivers Whole Food Nutrition; Beat Crazy Cocoa Prices with Synergy's Chocolate Flavors
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Heart Health Alert: Niacin May Reverse Hardening of the Arteries
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Spotlight on Savory Side Dishes
- Another Reason to Choose Healthy Lifestyle Habits
- Another Reason to Choose Healthy Lifestyle Habits
|
BOSTON, Feb 25, 2005 (BUSINESS WIRE) -- Joslin Scientists also Discover this Impairment in Low Birth Weight Babies Sets the Stage for Type 2 Diabetes Later in Life
Scientists at Joslin Diabetes Center have discovered one reason why infants with low birth weight have a high potential of developing type 2 diabetes later in life. In studies of mice, the researchers found that poor prenatal nutrition impairs the pancreas's ability to later secrete enough insulin in response to blood glucose.
"The bottom line is that if you don't have delivery of enough nutrients from the mother to the baby, the baby's pancreatic cells will be programmed abnormally," said principal investigator Mary-Elizabeth Patti, M.D., Assistant Investigator in Joslin's Research Section on Cellular and Molecular Physiology and Assistant Professor of Medicine at Harvard Medical School. "The effect doesn't show up until later on -- usually not until adolescence or adulthood.
"Many people believe we don't have much of a prenatal nourishment problem in the United States," she added. "But poor nutrition of a developing baby can occur in many ways other than inadequate nutrition of the mother. It also can occur with abnormal development of the placenta and its blood vessels, or high blood pressure, which damages vessels." In addition, many other factors can result in intrauterine growth restriction and low birth weight.
According to the Centers for Disease Control and Prevention (CDC), the incidence of low birth weight babies in the U.S. increased 12 percent between 1980 and 2000 among babies weighing 2500 grams (5 1/2 pounds), and the rate is up 24 percent in babies weighing 1500 grams or less in that timeframe. The CDC reports that 314,077 low birth weight babies were born in 2002, representing 7.8 percent of the births that year, the highest level reported in more than three decades. This is due in part to the increase in the number of multiple births, which also are on the increase.
The Joslin study, published in the March edition of Diabetes, reinforces what scientists have known from previous studies in humans: Infants with low birth weight -- typically defined as under five and one-half pounds -- have a higher risk for developing type 2 diabetes.
To understand the reason, the researchers designed a series of experiments. Using ordinary mice that were not inbred or genetically altered in any way, they mated females with males, dating the day of their pregnancy, which lasts three weeks. They separated the mothers into two groups. The control group ate as much chow as they wanted during the entire pregnancy. The other group also was fully nourished during the first two weeks but undernourished during the third week, restricted to only half the amount. It had a dramatic effect. At birth, their babies weighed 23 percent less than the control group.
After delivery, all babies nursed and all mothers ate a full diet. "By the time the babies were weaned, at three weeks, the low-birth-weight group had caught up with the others, something we see in human babies too," said Dr. Patti. "They looked and acted the same. There was nothing outwardly different about them." The two groups of offspring ate the same chow diet, maintained a similar weight, and neither group was allowed to become overweight, eliminating this common risk factor for diabetes. The only difference was that the mothers had been fed differently during the final week.
As the young mice matured, the researchers tested their blood glucose (sugar) after meals. At age 2 months, the results were similar between the two groups. But over time, differences began to unfold. When 4 months old (comparable to human adolescence), the low-birth-weight babies began showing higher levels of blood glucose. "By 6 months, these levels had spiked abnormally, to 500 mg/dl -- the equivalent of serious, full-blown diabetes in humans," Dr. Patti said.
In type 1 diabetes, the pancreas cannot make the hormone insulin at all; about 1 million Americans must control this form by taking insulin injections. In type 2 -- a disorder affecting an estimated 18 million Americans -- the pancreas doesn't make enough insulin or the body's cells develop a resistance to its effect. Without insulin, glucose cannot get into cells to provide energy.
Normally, insulin levels rise or drop in response to glucose levels, keeping everything in balance. But diabetes is a complex metabolic disorder with numerous players such as high levels of blood glucose, cholesterol and other lipids. "The challenge is to figure out which factors are a primary cause of diabetes and which are a consequence, said Dr. Patti. "In our study, we needed to find out what was happening in these mice, before they got the problem."
Their insulin levels provided a clue. In the prenatally undernourished mice, the insulin secretion stayed about the same, regardless of the glucose level in the bloodstream. "That surprised us," Dr. Patti said. "The problem was not insulin resistance. It had something to do with insulin secretion." By contrast, babies who are born overweight (greater than 8 pounds) have higher risk of insulin resistance, not a secretion problem. Something different was happening in the experiment's low-birth-weight mice.
Did prenatal undernourishment cause the pancreas to not fully develop? The researchers found no difference in pancreas size or numbers of pancreatic beta cells, which produce insulin.
But cultures of the beta cells revealed the answer: the undernourished mice had an abnormal way of responding to glucose. "They were somehow 'programmed' to secrete a limited amount of insulin later in life, no matter what signal they got from glucose," Dr. Patti said. "The impairment was permanent. It couldn't be corrected even when the body caught up to normal weight."
Because studies of mice generally are good predictors of human biology, the Joslin study has important implications. "People and their doctors need to understand that prenatal undernourishment makes a person permanently at higher risk for developing diabetes, so prenatal care is important," Dr. Patti said. "Moreover, if someone was born with low weight, they need to pay special attention to prevention tactics, including exercise and weight control to minimize insulin resistance -- the other major factor involved in triggering type 2 diabetes.
"In particular, someone who was a low-birth-weight baby can compound the risk of developing diabetes by becoming overweight," she added. "The stage is set in two ways: low insulin production coupled with resistance to insulin -- a double whammy."
Other researchers involved in the Joslin study included co-authors Jose C. Jimenez-Chillaron, Ph.D., Marcelino Hernandez-Valencia, M.D.; also Carolyn Reamer, Simon Fisher, M.D., Ph.D., Allison Joszi, Ph.D., Michael Hirshman, Aysin Oge, M.D., Shana Walrond, Roberta Przybyla, Carol N. Boozer, D.Sc., of St. Luke's-Roosevelt Hospital Center in New York, and Laurie Goodyear, Ph.D., head of the Section on Metabolism at Joslin. The research was funded by the American Diabetes Association and the Adler Foundation. |